Expression and Clinical Significance of MPS-1 in Hepatocellular Carcinoma

Código QR

Expression and Clinical Significance of MPS-1 in Hepatocellular Carcinoma

He Jiang, Feifei Yuan, Zhiying Zhao, Tongchun Xue, Ningling Ge, Zhenggang Ren, Lan Zhang Department of Hepatic Oncology, Zhongshan Hospital, Liver Cancer Institute and Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence: Lan Zhan...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jiang H, Yuan F, Zhao Z, Xue T, Ge N, Ren Z, Zhang L
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	hepatocellular carcinoma ribosomal protein mps-1 biomarker prognosis Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/27394dbd7b47429da7559893462da614
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Exploring the Prognostic Value, Immune Implication and Biological Function of H2AFY Gene in Hepatocellular Carcinoma
por: Yongbiao Huang, et al.
Publicado: (2021)

Elevated DNA Polymerase Delta 1 Expression Correlates With Tumor Progression and Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma
por: Shuai Zhao, et al.
Publicado: (2021)

Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis
por: Zongcai Yan, et al.
Publicado: (2021)

Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma
por: Xiao-Wei Fu, et al.
Publicado: (2021)

Prognostic significance of TRIM28 expression in patients with breast carcinoma
por: Zhang Wen, et al.
Publicado: (2021)

Correlation Between cyclin G1 Expression and Efficacy of Radiotherapy on Primary Hepatocellular Carcinoma
por: XU Gang, et al.
Publicado: (2021)

Comprehensive Analysis of LPCATs Highlights the Prognostic and Immunological Values of LPCAT1/4 in Hepatocellular Carcinoma
por: Lin T, et al.
Publicado: (2021)

Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma
por: Yang Yang, et al.
Publicado: (2021)

Expression and Prognostic Role of E2F2 in Hepatocellular Carcinoma
por: Shen S, et al.
Publicado: (2021)

Assessment of Prognostic Value of Aspartate Aminotransferase-to-Platelet Ratio Index in Patients With Hepatocellular Carcinoma: Meta-Analysis of 28 Cohort Studies
por: XinYue Zhang, et al.
Publicado: (2021)

PRRC2A Promotes Hepatocellular Carcinoma Progression and Associates with Immune Infiltration
por: Liu X, et al.
Publicado: (2021)

A Novel Nine-Gene Signature Associated With Immune Infiltration for Predicting Prognosis in Hepatocellular Carcinoma
por: Rongqiang Liu, et al.
Publicado: (2021)

Identification of a Pyroptosis-Related Gene Signature for Predicting Overall Survival and Response to Immunotherapy in Hepatocellular Carcinoma
por: Susu Zheng, et al.
Publicado: (2021)

Effect of Microvascular Invasion on the Prognosis in Hepatocellular Carcinoma and Analysis of Related Risk Factors: A Two-Center Study
por: Wang Yanhan, et al.
Publicado: (2021)

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment
por: Luo M, et al.
Publicado: (2021)

Development and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma
por: Zeng-Hong Wu, et al.
Publicado: (2021)

An lncRNA Model for Predicting the Prognosis of Hepatocellular Carcinoma Patients and ceRNA Mechanism
por: Hao Zhang, et al.
Publicado: (2021)

Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
por: Changjing Huang, et al.
Publicado: (2021)

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment [Corrigendum]
por: Luo M, et al.
Publicado: (2021)

Prognostic Influence of Spontaneous Tumor Rupture in Patients With Hepatocellular Carcinoma After Hepatectomy: A Meta-Analysis of Observational Studies
por: Jiaxuan Xu, et al.
Publicado: (2021)

Association Between Procalcitonin and Post-hepatectomy Liver Failure in Hepatocellular Carcinoma Patients
por: Yi-Ran Li, et al.
Publicado: (2021)

Analysis of Multi-Layer RNA Modification Patterns for the Characterization of Tumor Immune Microenvironment in Hepatocellular Carcinoma
por: Jiyuan Xing, et al.
Publicado: (2021)

Integration Analysis of m6A Regulators and m6A-Related Genes in Hepatocellular Carcinoma
por: Jingdun Xie, et al.
Publicado: (2021)

Identification of the Pyroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Hepatocellular Carcinoma
por: Shuang Liu, et al.
Publicado: (2021)

A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis
por: Jianhua Wu, et al.
Publicado: (2021)

IMMUNOHISTOCHEMICAL EXPRESSION OF GLYPICAN-3 IN HEPATOCELLULAR CARCINOMA
por: Dr Syed Salman Ali, et al.
Publicado: (2018)

Supervised learning based on tumor imaging and biopsy transcriptomics predicts response of hepatocellular carcinoma to transarterial chemoembolization
por: Tuyana Boldanova, et al.
Publicado: (2021)

Integrated Bioinformatics Analysis Identifies Heat Shock Factor 2 as a Prognostic Biomarker Associated With Immune Cell Infiltration in Hepatocellular Carcinoma
por: Yumei Fan, et al.
Publicado: (2021)

Gender sensitivity of the Serbian parliament: Mapping the power of women MPs
por: Vukomanović Dijana P.
Publicado: (2021)

Expression and clinical significance of CMTM1 in hepatocellular carcinoma
por: Song Xin, et al.
Publicado: (2021)

Increased Serum Pentraxin 3 Levels are Associated with Poor Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Han Q, et al.
Publicado: (2021)

miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]
por: Li F, et al.
Publicado: (2020)

Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma
por: Shuai Li, et al.
Publicado: (2021)

Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma
por: Anmin Huang, et al.
Publicado: (2021)

Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis
por: Flavia Fondevila, et al.
Publicado: (2021)

The Significance of Circulating Cell-Free DNA Markers in Chronic Hepatitis B Patients with Hepatocellular Carcinoma
por: Alkistis Papatheodoridi, et al.
Publicado: (2021)

miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker
por: Li F, et al.
Publicado: (2018)

NDRG2 inhibition facilitates angiogenesis of hepatocellular carcinoma
por: Wang Jianlong, et al.
Publicado: (2021)

Identification and Validation of an 6-Metabolism-Related Gene Signature and Its Correlation With Immune Checkpoint in Hepatocellular Carcinoma
por: He Ren, et al.
Publicado: (2021)

A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients
por: Dingde Ye, et al.
Publicado: (2021)